132 results
What do we know about convalescent plasma therapy (CPT) for COVID-19? Read this new EBM Focus article to find out.
Antiviral monoclonal antibody therapy is authorized for outpatients with mild-to-moderate COVID-19 at high risk for clinical progression. Read about this new therapy from the Infectious Disease team at DynaMed®.
Hydroxychloroquine (with or without azithromycin) has received a lot of media attention for the treatment of COVID-19, but is there evidence that it works?
With millions of people around the world vaccinated with an mRNA-based vaccine for COVID-19, here’s a sneak peek into the body to see how they work.
This EBM Focus article dissects a trial evaluating inhaled budesonide for COVID-19 recovery, including the Bayesian methodology used in its analysis.
Two years into the COVID-19 pandemic, SARS-CoV-2 continues to evolve and public health guidance evolves with it. Here are five key turning points in mask recommendations.
Clinical Decision Support Systems (CDSS) can offer clinicians on the frontlines of the COVID-19 pandemic fast access to evidence-based protocols, but what should be considered when choosing one?
The EBM Focus team at DynaMed® presents its favorite summaries of clinical trials from 2020.
For Suicide Prevention Week, DynaMed® editors discuss the importance of mental health care for clinicians, especially during times of crisis like the current COVID-19 pandemic.
While the COVID-19 pandemic continues to impact people worldwide, it is not the only coronavirus the world is battling in 2020. The MERS outbreak is still ongoing in the Middle East. Learn more about MERS from our partners at GIDEON.